RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

NCT06146101 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

560

Enrollment

INDUSTRY

Sponsor class

Conditions

Obstructive Sleep Apnea

Interventions

DRUG: IHL-42X Low Dose
DRUG: IHL-42X High Dose
DRUG: Placebo
DRUG: IHL-42X (Optimal Dose)
DRUG: Dronabinol
DRUG: Acetazolamide
DRUG: Placebo

Sponsor

Incannex Healthcare Ltd